Stereotactic radiosurgery, like that delivered by CyberKnife, has become the “standard of care” for stage 1 lung cancer patients considered to be medically inoperable or if a patients is too sick for surgery. A new study of 62,213 patients 60 years and older with stage 1 lung cancer, showed that stereotactic radiosurgery increased the 2 year survival rate to 58% compared to 39% for seniors treated with conventional radiation.
Dr. Andrew Farach told HemOnc Today that “Our findings indicate that physicians should feel confident recommending radiation therapy to patients who are too sick to undergo surgery or choose not to undergo surgery for other reasons.”
THE CYBERKNIFE ADVANTAGE
CyberKnife is the only stereotactic radiosurgery device that continuously tracks your lung cancer as you breathe. CyberKnife treatments are painless-no incision. CyberKnife treatments are completed in only 3-5 outpatient visits. In fact, many of our patients can drive themselves to and from visits.
Many of our seniors have many medical problems that limit their surgical options. And CyberKnife is a perfect alternative. At the prestigious Massachusetts General Hospital in Boston, there has been a drop in surgery for seniors with early-stage lung cancer with many choosing stereotactic radiosurgery.
“It is a rare situation where the more convenient therapy is also the more effective therapy,” said Dr. Farach of Houston’s Methodist Hospital.
If you have any questions about your lung cancer, please feel free to call me, Dr. Edward Hughes, at 855-Dayton 1. I guarantee that I will see you in 1-3 days of your call. Expertise. Experience. Caring. The First Dayton CyberKnife difference.